Clinical Trial Update: Serum Cystatin C for Early Detection of Acute Kidney Injury After Primary Percutaneous Coronary Intervention

View source ↗

Summary

This clinical trial investigates whether serum cystatin C can serve as an early biomarker for detecting acute kidney injury after primary percutaneous coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: Assiut University | Conditions: Acute Kidney Injury | Status: NOT_YET_RECRUITING